Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on July 1, 2006

Papers In Press, published online ahead of print April 25, 2006
J. Lipid Res., doi:10.1194/jlr.M600005-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M600005-JLR200v1
47/7/1366    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castellani, L. W.
Right arrow Articles by Reynolds, W. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castellani, L. W.
Right arrow Articles by Reynolds, W. F.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on January 6, 2006
Revised on April 25, 2006
Accepted on April 25, 2006

Transgenic mice express human MPO -463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in -463G males

Lawrence W. Castellani, James J. Chang, Xuping Wang, Aldons J. Lusis, and Wanda F. Reynolds

Molecular Biology, Sidney Kimmel Cancer Center, San Diego, Ca 92121

Corresponding Author: wreynolds{at}skcc.org

Myeloperoxidase (MPO) is an oxidant-generating enzyme present in macrophages at atherosclerotic lesions and implicated in cardiovascular disease (CAD). While mouse models are important for investigating the role of MPO in atherosclerosis, neither mouse MPO nor its oxidation products are detected in lesions in murine models. To circumvent this problem, we generated transgenic mice expressing two functionally different human MPO alleles, with either G or an A at position –463, and crossed these to the LDLR-/- mouse. The –463G allele is linked to higher MPO expression and increased CAD incidence in humans. Both MPO alleles were expressed in a subset of lesions in high fat-fed LDLR-/- mice, notably at necrotic lesions with cholesterol clefts. MPOG-expressing LDLR-/- males (but not females) developed significantly higher serum cholesterol, triglycerides, and glucose, all correlating with increased weight gain/obesity, implicating MPO in lipid homeostasis. The MPOG- and A-LDLR-/- males also exhibited significantly larger aortic lesions than control LDLR-/- males. The human MPO transgenic model will facilitate studies of MPO involvement in atherosclerosis and lipid homeostasis.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
S. J. Nicholls and S. L. Hazen
Myeloperoxidase, modified lipoproteins, and atherogenesis
J. Lipid Res., April 1, 2009; 50(Supplement): S346 - S351.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. A. Maki, V. A. Tyurin, R. C. Lyon, R. L. Hamilton, S. T. DeKosky, V. E. Kagan, and W. F. Reynolds
Aberrant Expression of Myeloperoxidase in Astrocytes Promotes Phospholipid Oxidation and Memory Deficits in a Mouse Model of Alzheimer Disease
J. Biol. Chem., January 30, 2009; 284(5): 3158 - 3169.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement